The Experts below are selected from a list of 240 Experts worldwide ranked by ideXlab platform
Erkan Yavuz - One of the best experts on this subject based on the ideXlab platform.
-
Diverting Ileostomy Duration Is the Main Determinant of Ileostomy-Related Complications after Surgical Treatment of Rectum Cancer.
Journal of oncology, 2020Co-Authors: Nadir Adnan Hacım, Ahmet Akbas, Serhat Meric, Yuksel Altinel, Onder Karabay, Erkan YavuzAbstract:This study aimed to investigate factors associated with the development of Ileostomy complications in rectal cancer patients, including those who received neoadjuvant treatment. This retrospective trial included 133 consecutive patients who underwent surgery for rectal cancer with temporary diverting Ileostomy. Patients' demographic characteristics as well as the pre- and postclosure outcomes and complications were analyzed. In logistic regression analysis, longer duration of Ileostomy emerged as a significant independent predictor of any complication during Ileostomy. The respective odds ratios for 3-6 months and >6 months vs. <3 months of Ileostomy duration were as follows: OR, 4.5 (95% CI, 1.2-16.7), p=0.023; and OR, 15.2 (95% CI, 3.1-75.2), p=0.001. An additional stepwise model also identified hypertension as a significant predictor. In stepwise logistic regression model, adjuvant chemoradiotherapy emerged as significant independent predictor of "any Ileostomy-related complication after Ileostomy closure": OR, 4.5 (2.0-10.2), p < 0.001. Duration of Ileostomy appears to be the main determinant of Ileostomy-related complications. Patients who had received neoadjuvant or adjuvant therapy had longer Ileostomy duration, which may be attributed to the concerns of the surgeon or to the complications themselves. Copyright © 2020 Nadir Adnan Hacim et al.
-
Diverting Ileostomy Duration Is the Main Determinant of Ileostomy-Related Complications after Surgical Treatment of Rectum Cancer.
Journal of oncology, 2020Co-Authors: Nadir Adnan Hacım, Ahmet Akbas, Serhat Meric, Yuksel Altinel, Onder Karabay, Erkan YavuzAbstract:Background This study aimed to investigate factors associated with the development of Ileostomy complications in rectal cancer patients, including those who received neoadjuvant treatment. Methods This retrospective trial included 133 consecutive patients who underwent surgery for rectal cancer with temporary diverting Ileostomy. Patients' demographic characteristics as well as the pre- and postclosure outcomes and complications were analyzed. Results In logistic regression analysis, longer duration of Ileostomy emerged as a significant independent predictor of any complication during Ileostomy. The respective odds ratios for 3-6 months and >6 months vs.
M R B Keighley - One of the best experts on this subject based on the ideXlab platform.
-
randomized trial of loop Ileostomy in restorative proctocolectomy
British Journal of Surgery, 2005Co-Authors: S P Grobler, K B Hosie, M R B KeighleyAbstract:A randomized controlled trial was performed to assess the role of loop Ileostomy in totally stapled restorative proctocolectomy. Entry criteria included all patients who were not on corticosteroids in whom on-table testing revealed a watertight pouch with intact ileoanal anastomosis. Of 59 patients undergoing restorative proctocolectomy over 36 months, 45 were eligible and were randomized to loop Ileostomy (n = 23) or no Ileostomy (n = 22). The age and diagnosis of the groups were similar. There were no deaths; two ileoanal anastomotic leaks occurred, one in each group. Ileoanal stenosis occurred in five patients with and one without an Ileostomy. The incidences of wound and pelvic sepsis, bowel obstruction and pouchitis were similar. Twelve patients (52 per cent) developed Ileostomy-related complications. The median total hospital stay was 23 (range 13-75) days with Ileostomy and 13 (range 7-119) days without (P < 0.001). This study indicates that there is a low risk of pelvic sepsis which is not increased by avoiding a protective Ileostomy. Loop Ileostomy was associated with a high incidence of complications.
-
stapled versus sutured closure of loop Ileostomy a randomized controlled trial
Annals of Surgery, 2000Co-Authors: Hirotoshi Hasegawa, S Radley, Dion Morton, M R B KeighleyAbstract:ObjectiveTo compare the outcome after conventional sutured loop Ileostomy closure with stapled Ileostomy closure.Summary Background DataA defunctioning loop Ileostomy is now widely used in colorectal surgery. Subsequent closure may be associated with early complications, particularly bowel obstructi
K. I. Deen - One of the best experts on this subject based on the ideXlab platform.
-
Complications of loop Ileostomy and Ileostomy closure and their implications for extended enterostomal therapy: a prospective clinical study.
International journal of nursing studies, 2007Co-Authors: M.m.g. Rathnayake, S.k. Kumarage, S.r.e. Wijesuriya, B.n.l. Munasinghe, M.h.j. Ariyaratne, K. I. DeenAbstract:Abstract Introduction Patients who have a temporary loop Ileostomy have impaired quality of life. Complications associated with a loop Ileostomy or Ileostomy closure will impair patients' quality of life further and require extended enterostomal therapy. We performed a prospective audit of loop Ileostomy to ascertain the nature of the workload that may be created with Ileostomy-related complications. Patients and methods One hundred and forty patients (67 males, 73 females, median age 50 years, range 5–90 years) who received a temporary loop Ileostomy were analysed after completion of proformas on a prospective basis between 1999 and 2006. Results Operation was performed for rectal cancer 100 (71%), familial adenomatous polyposis 14 (10%), ulcerative colitis 21 (15%) and for trauma or Hirchsprung's disease 5 (3%). Complications of loop Ileostomy were: retraction 1 (0.7%), Ileostomy flux 11 (8%), stomal prolapse 1 (0.7%), parastomal hernia 1 (0.7%), paraIleostomy abscess 4 (3%) and severe skin excoriation 9 (6%). The loop Ileostomy was reversed in 117 (83%) at a median (range) of 13 weeks (1–60). Ileostomy closure-related complications were: small bowel fistula 1 (0.9%), small bowel obstruction 5 (4.3%) and a stitch sinus in 1 (0.9%). Five women developed recto-vaginal fistula ( n =3; 2.6%), pouch-vaginal fistula ( n= 1; 0.9%) and pouch-anal fistula ( n =1; 0.9%) that required extended enterostomal therapy, after loop Ileostomy reversal. Conclusion Nineteen percent of patients following creation of a loop Ileostomy and 10.5% of patients after reversal of the Ileostomy required extended enterostomal care by a specialized enterostomal therapist, which supported resumption of a normal life.
-
quality of life of stoma patients temporary Ileostomy versus colostomy
World Journal of Surgery, 2003Co-Authors: Michael A Silva, Geethani Ratnayake, K. I. DeenAbstract:Abstract Ileostomy for proximal diversion as a preferred option over colostomy has been a recent topic of interest. Our study evaluated the quality of life (QOL) of patients with a temporary Ileostomy and compared it with that of patients with a temporary colostomy. The QOL of 25 patients with an Ileostomy (median age 42 years, range 22–76 years) was compared with that for 25 patients with a colostomy (median age 44 years, range 18–70 years). Indications for a stoma were rectal carcinoma, trauma, inflammatory bowel disease, anastomotic leak, or incontinence following an operative procedure for rectal prolapse. The study was conducted at a median of 8 weeks (range 6–16 weeks) for Ileostomy patients and of 9 weeks (range 5–17 weeks) for colostomy patients following stoma creation. A self-administered structured questionnaire was used, with responses obtained for 10 QOL questions on a visual analog rating scale (0–100 mm); they were graded good (71–100), satisfactory (31–70), or poor (0–30). Altogether, 22 (88%) patients with an Ileostomy, compared with 16 (64%) patients with a colostomy, were able to purchase their stomal appliances (p = 0.09, χ 2: NS). Effluent was tolerable in 18 (72%) patients with an Ileostomy compared with 7 (28%) patients with a colostomy (p = 0.002, χ 2). Appetite was not affected in any of the patients with an Ileostomy (100%), compared with 64% of patients with a colostomy (p = 0.002, χ 2), travel by public transport 32% compared to 28% with colostomy (NS), dress in 20% compared to 24% with colostomy (NS), and daily activities 28% compared to 24% with colostomy (NS). Moreover, 68% with an Ileostomy did not have a problem with hygiene compared with 40% with a colostomy (NS); 95% with an Ileostomy abstained from sexual activity compared with 81% with a colostomy (p = 0.21, χ 2: NS). Both Ileostomy and colostomy resulted in significant QOL impairment. However, with Ileostomy, the effluent was more tolerable, had less of an impact on personal hygiene, and preserved the appetite compared with colostomy. There were no differences in travel, dress, daily chores, or sexual activity between the two groups.
Nadir Adnan Hacım - One of the best experts on this subject based on the ideXlab platform.
-
Diverting Ileostomy Duration Is the Main Determinant of Ileostomy-Related Complications after Surgical Treatment of Rectum Cancer.
Journal of oncology, 2020Co-Authors: Nadir Adnan Hacım, Ahmet Akbas, Serhat Meric, Yuksel Altinel, Onder Karabay, Erkan YavuzAbstract:This study aimed to investigate factors associated with the development of Ileostomy complications in rectal cancer patients, including those who received neoadjuvant treatment. This retrospective trial included 133 consecutive patients who underwent surgery for rectal cancer with temporary diverting Ileostomy. Patients' demographic characteristics as well as the pre- and postclosure outcomes and complications were analyzed. In logistic regression analysis, longer duration of Ileostomy emerged as a significant independent predictor of any complication during Ileostomy. The respective odds ratios for 3-6 months and >6 months vs. <3 months of Ileostomy duration were as follows: OR, 4.5 (95% CI, 1.2-16.7), p=0.023; and OR, 15.2 (95% CI, 3.1-75.2), p=0.001. An additional stepwise model also identified hypertension as a significant predictor. In stepwise logistic regression model, adjuvant chemoradiotherapy emerged as significant independent predictor of "any Ileostomy-related complication after Ileostomy closure": OR, 4.5 (2.0-10.2), p < 0.001. Duration of Ileostomy appears to be the main determinant of Ileostomy-related complications. Patients who had received neoadjuvant or adjuvant therapy had longer Ileostomy duration, which may be attributed to the concerns of the surgeon or to the complications themselves. Copyright © 2020 Nadir Adnan Hacim et al.
-
Diverting Ileostomy Duration Is the Main Determinant of Ileostomy-Related Complications after Surgical Treatment of Rectum Cancer.
Journal of oncology, 2020Co-Authors: Nadir Adnan Hacım, Ahmet Akbas, Serhat Meric, Yuksel Altinel, Onder Karabay, Erkan YavuzAbstract:Background This study aimed to investigate factors associated with the development of Ileostomy complications in rectal cancer patients, including those who received neoadjuvant treatment. Methods This retrospective trial included 133 consecutive patients who underwent surgery for rectal cancer with temporary diverting Ileostomy. Patients' demographic characteristics as well as the pre- and postclosure outcomes and complications were analyzed. Results In logistic regression analysis, longer duration of Ileostomy emerged as a significant independent predictor of any complication during Ileostomy. The respective odds ratios for 3-6 months and >6 months vs.
Paris Tekkis - One of the best experts on this subject based on the ideXlab platform.
-
comparison of outcomes following Ileostomy versus colostomy for defunctioning colorectal anastomoses
World Journal of Surgery, 2007Co-Authors: H S Tilney, Parvinder Sains, Richard E Lovegrove, George E Reese, Alexander G Heriot, Paris TekkisAbstract:The present study evaluated outcomes of patients undergoing proximal diversion using either a loop Ileostomy or loop colostomy following distal colorectal resection for malignant and non-malignant disease. A literature search of the Medline, Ovid, Embase and Cochrane databases was performed to identify studies published between 1966 and 2006, comparing loop Ileostomy and loop colostomy to protect a distal colorectal anastomosis. A random effect meta-analytical technique was used and sensitivity analysis performed on studies published since 2000, higher quality papers, those reporting on 70 or more patients, and those reporting outcomes following colorectal cancer resections. Seven studies, including three randomised controlled trials, satisfied the inclusion criteria. Outcomes of a total of 1,204 patients were analysed, of whom 719 (59.7%) underwent defunctioning loop Ileostomy. High stoma output was more common following Ileostomy formation (OR = 5.39, 95% CI: 1.11, 26.12, P = 0.04), but wound infections following their reversal were significantly fewer (OR = 0.21, 95% CI: 0.07, 0.62, P = 0.004). Overall complications were less frequent for Ileostomy patients in the subgroup of high quality studies (OR = 0.22, 95% CI: 0.08, 0.59, P = 0.003). The results of this meta-analysis suggest that Ileostomy may be preferable to colostomy when used to defunction a distal colorectal anastomosis. Wound infections following stoma reversal were reduced, as were overall stoma-related complications and incisional hernia following stoma reversal for Ileostomy patients in high quality studies.
